Results 171 to 180 of about 1,543,151 (246)
Autonomous Nanomedicine: Closing the Biological Validation Gap
Delivery of nanoparticles to tumors has not improved in over fifteen years, and biological testing remains slow and separate from formulation design. This review proposes adding a Biology step to the design cycle, using organ chips and patient‐derived organoids, and assesses the readiness of each required technology.
Yan Jun Lin, Izabella Komperda
wiley +1 more source
Mollugin from Rubia cordifolia modulates cancer‐related signaling, apoptosis, autophagy, ferroptosis and inflammation in preclinical models. Its use in functional foods or nutraceuticals remains unestablished, requiring authenticated preparations, defined oral exposure, comprehensive toxicological assessment, and human evidence of safety and efficacy ...
Mert İlhan +5 more
wiley +1 more source
Oral Bacterial Extracellular Vesicles as Systemic Messengers: A Mouth–Gut–Systemic Axis Paradigm
ABSTRACT Oral microbiome dysbiosis not only associated with localized periodontal disease but also with multiple systemic diseases, including cardiovascular disease, diabetes mellitus, Alzheimer's disease, rheumatoid arthritis, and cancer. However, the efficiency with which intact viable bacteria cross biological barriers to reach distant organs is ...
Yaping Huang +5 more
wiley +1 more source
ABSTRACT Introduction Cancer cachexia is characterized by skeletal muscle loss, poor nutrition, and systemic inflammation and is common in head and neck cancer. We evaluated whether the Cachexia Index (CXI) predicts treatment toxicity and survival in HPV‐negative HNSCC.
Gianluca Savoia +11 more
wiley +1 more source
ABSTRACT Spot‐based spatial transcriptomics (ST) allows for unbiased gene expression analysis within tissue architecture, overcoming the limitations of single‐cell RNA sequencing (scRNA‐seq) by preserving spatial context. However, the high spatial resolution in ST leads to cellular heterogeneity within spots, requiring computational deconvolution to ...
Stefan Altendorfer +2 more
wiley +1 more source
Physical Activity and Risk of Liver Cancer: A Competing Risk Analysis
ABSTRACT Physical activity is associated with lower risk of liver cancer, but obtaining an unbiased estimate of the causal effect is challenging due to the competing risk of death due to any other cause. We performed a causal competing risk analysis to estimate the total effect of physical activity on risk of liver cancer in the presence of competing ...
Frances E. M. Albers +9 more
wiley +1 more source
Activity of Low Dose Nivolumab in Patients With Advanced Squamous Cell Carcinomas and Other Cancers
ABSTRACT Immune checkpoint inhibitors such as anti–PD‐1 antibodies are essential in cancer therapy. Emerging data suggest that lower doses may be effective and more economical, though further evidence is needed. We conducted a retrospective study at Centre Léon Bérard to assess the efficacy and safety of low‐dose nivolumab (20 mg every 3 weeks) in ...
Thibault Gauduchon +16 more
wiley +1 more source
ABSTRACT Twenty‐five percent of colon cancer patients having curative surgery will recur. Most of them will die from distant metastasis partly due to shortcomings of routine histopathological analysis, that is, undetected tumor cells in the regional lymph node field.
Basel Sitohy +20 more
wiley +1 more source
UICC TNM 9th Edition Updates: Cancers of the Colon and Rectum
ABSTRACT The expanding medical knowledge of tumour behaviour and advances in imaging, pathology, and therapeutic options require that TNM to be regularly updated. The 9th edition of the Union for International Cancer Control (UICC) TNM Classification of Malignant Tumours was published in 2025 [UICC 9th Edition (2025)] to take effect on January 2026 ...
James D. Brierley +7 more
wiley +1 more source

